BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14599982)

  • 1. Detection of distribution of copper inside and outside of lysosomes in cultured hepatolenticular degeneration fibroblasts by electron probe X-ray microanalysis.
    Liu W; Li JY; Jin J; Zuo J
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):270-3. PubMed ID: 14599982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study on the pathogenesis of hepatolenticular degeneration using an in vitro model].
    Chen XZ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Jun; 22(3):133-5, 190. PubMed ID: 2591264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Copper level and metallothionein-like Cu-binding protein in cultured skin fibroblasts from patients with Menkes' disease and Wilson's disease].
    Sato M; Hayashi A; Ito H; Tojo M; Arima M
    No To Shinkei; 1984 Nov; 36(11):1063-8. PubMed ID: 6525319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical curative effects of dimercaptosuccinic acid on hepatolenticular degeneration and the impact of DMSA on biliary trace elements.
    Ren M; Yang R
    Chin Med J (Engl); 1997 Sep; 110(9):694-7. PubMed ID: 9642327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electron probe X-ray analysis on human hepatocellular lysosomes with copper deposits: copper binding to a thiol-protein in lysosomes.
    Hanaichi T; Kidokoro R; Hayashi H; Sakamoto N
    Lab Invest; 1984 Nov; 51(5):592-7. PubMed ID: 6492760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrahepatocellular localization of copper in Wilson's disease.
    Yano M; Sakamoto N; Takikawa T; Hayashi H
    Nagoya J Med Sci; 1993 Mar; 55(1-4):131-7. PubMed ID: 8247102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of gandou decoction on copper metabolism of skin fibroblast of hepatolenticular degeneration model].
    Tang Q; Yang R; Han Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Jan; 20(1):37-9. PubMed ID: 11783335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electron microscopic detection of copper in the liver of two patients with morbus Wilson by EELS and EDX.
    Jonas L; Fulda G; Salameh T; Schmidt W; Kröning G; Hopt UT; Nizze H
    Ultrastruct Pathol; 2001; 25(2):111-8. PubMed ID: 11407524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electron probe microanalysis of liver in Wilson's disease. Simultaneous assay for copper and for lead deposited by acid phosphatase activity in lysosomes.
    Goldfischer S; Moskal J
    Am J Pathol; 1966 Feb; 48(2):305-15. PubMed ID: 5904503
    [No Abstract]   [Full Text] [Related]  

  • 10. A copper-sulfur complex in the liver of a patient with Wilson's disease.
    Sasa A; Hayashi H; Yagi A; Ohguchi S; Kidokoro R; Sato Y; Sakamoto N
    Gastroenterol Jpn; 1986 Dec; 21(6):633-7. PubMed ID: 3569749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight copper binding proteins in Wilson disease.
    Rodo M; Wehr H; Wald I
    Acta Anthropogenet; 1985; 9(1-3):63-70. PubMed ID: 3843748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of iron distribution in liver cells in beta-thalassemia studied by X-ray microanalysis.
    Faa G; Terlizzo M; Gerosa C; Congiu T; Angelucci E
    Haematologica; 2002 May; 87(5):479-84. PubMed ID: 12010660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular degeneration).
    Sternlieb I; Van den Hamer CJ; Morell AG; Alpert S; Gregoriadis G; Scheinberg IH
    Gastroenterology; 1973 Jan; 64(1):99-105. PubMed ID: 4683859
    [No Abstract]   [Full Text] [Related]  

  • 14. [Detection of hepatic copper by physical methods. Importance of X-ray spectrography].
    Rauber G; Martin JA; Duprez A; Chevin JC; Emile-Chevalier C
    Med Chir Dig; 1981; 10(4):333-5. PubMed ID: 7300489
    [No Abstract]   [Full Text] [Related]  

  • 15. Three stages of copper accumulation in hepatocellular lysosomes: X-ray microanalysis of copper-loaded golden hamsters.
    Yagi A; Hayashi H; Higuchi T; Hishida N; Sakamoto N
    Int J Exp Pathol; 1992 Feb; 73(1):85-94. PubMed ID: 1576079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the distribution of hepatic copper in relation to the progression of Wilson's disease (hepatolenticular degeneration).
    Goldfischer S; Sternlieb I
    Am J Pathol; 1968 Dec; 53(6):883-901. PubMed ID: 4177374
    [No Abstract]   [Full Text] [Related]  

  • 17. Estimation of the copper-iron correlation in the liver under experimental conditions. A microscopic and microchemical study.
    Cuida I; Onicescu D; Ionescu N
    Morphol Embryol (Bucur); 1980; 26(3):237-9. PubMed ID: 6453285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrathiomolybdate causes formation of hepatic copper-molybdenum clusters in an animal model of Wilson's disease.
    George GN; Pickering IJ; Harris HH; Gailer J; Klein D; Lichtmannegger J; Summer KH
    J Am Chem Soc; 2003 Feb; 125(7):1704-5. PubMed ID: 12580588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wilson's disease. Electron microscopic, x-ray energy spectroscopic, and atomic absorption spectroscopic studies of corneal copper deposition and distribution.
    Johnson RE; Campbell RJ
    Lab Invest; 1982 Jun; 46(6):564-9. PubMed ID: 7087389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perspective study on effect of gandou tablet I on biliary trace elements in treating hepatolenticular degeneration].
    Hu WB; Yang RM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Jul; 21(7):507-9. PubMed ID: 12575394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.